BostonGene logo

BostonGene Funding & Investors

BostonGene Corporation is pioneering the use of biomedical software for advanced patient analysis and personalized therapy decision making in the fight against cancer. BostonGene’s unique solution performs sophisticated analytics to aid clinicians in their evaluation of viable treatment options for each patient's individual genetics, tumor and tumor microenvironment, clinical characteristics and disease profile. BostonGene’s mission is to enable physicians to provide every patient with the highest probability of survival through optimal cancer treatments using advanced, personalized therapies

https://bostongene.com/

Total Amount Raised: $200,000,000

BostonGene Funding Rounds

  • Series B

    $150,000,000

    Series B Investors

    NEC
    Japan Industrial Partners
    Impact Investment Capital
  • Series A

    $50,000,000

    Series A Investors

    NEC
Funding info provided by Diffbot.